In a recent published report, Kenneth Research has updated the market report for Active Pharmaceutical Ingredients/API Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Active Pharmaceutical Ingredients/API Market products.
Kenneth Research has recently added a report titled Active Pharmaceutical Ingredients/API Market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2021 2030. Factors such as the growing advancements in the development of novel drugs, coupled with the growing health infrastructure in several nations worldwide are anticipated to drive the growth of the market in the coming years. Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth.
According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.
Kenneth Research recently added a report on ‘Active Pharmaceutical Ingredients/API Market’ in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on the COVID-19 impacts on the Active Pharmaceutical Ingredients/API Market, along with the compound growth rate (CAGR) of the market for a projected period between 2021 2025. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter’s five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.
The global Active Pharmaceutical Ingredients/APImarket was valued at USD 157.87billion in 2016 and is projected to reach USD 271.97billionby 2025, growing at a CAGR of 6.23% from 2017 to 2025. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. With increased investments and focus on API and its applications in R&D, the market is expected to grow at a high rate during the forecast period.
Download Sample of This Strategic Report:- https://www.kennethresearch.com/report-details/global-active-pharmaceutical-ingredientsapi-market/10008467
1. Market Drivers
1.1 Increasing Prevalence of chronic disorders
1.2 Increase cases of cancer
1.3 Technological advancements in API
1.4 Increasing geriatric population
1.5 Increasing scope of generics
1.6 Expansion of applications of biopharmaceuticals
2. Market Restraints
2.1 Unfavorable Drug pricing poilicies
2.2 Stringent regulations
1. By Therapeutic Application:
1.2 Cardiovascular Disease
1.4 Central Nervous System and Neurological Disorders
1.6 Other Therapeutic Applications
2. By Type of Drug:
2.1 Prescription Drugs
2.2 Over-The-Counter Drugs
2.3 Active Pharmaceutical Ingredients Market, By Potency
2.3.1 Low to Moderate Potency Active Pharmaceutical Ingredients
2.3.2 Potent to Highly Potent Active Pharmaceutical Ingredients
3. By Type of Synthesis:
3.1 Synthetic Active Pharmaceutical Ingredients
3.1.1 Innovative Synthetic APIs
3.1.2 Generic Synthetic APIs
3.2 Biotech Active Pharmaceutical Ingredients
3.2.1 By Type
184.108.40.206 Innovative Biotech APIs
3.2.2 By Product
220.127.116.11 Monoclonal Antibodies
18.104.22.168 Hormones and Growth Factors
22.214.171.124 Fusion Proteins
126.96.36.199 Therapeutic Enzymes
188.8.131.52 Blood Factors
3.2.3 By Expression System
184.108.40.206 Mammalian Expression Systems
220.127.116.11 Microbial Expression Systems
18.104.22.168 Yeast Expression Systems
22.214.171.124 Plant Expression Systems
126.96.36.199 Insect Expression Systems
4. By Type of manufacturer:
4.1 Captive Manufacturers
4.2 Merchant API Manufacturers
5. By Type:
5.1 Innovative Active Pharmaceutical Ingredients
5.2 Generic Active Pharmaceutical Ingredients
6. By Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
The major players in the market are as follows:
1. Pfizer, Inc.
2. Novartis International AG
5. Bristol-Myers Squibb
6. Teva Pharmaceutical Industries Ltd.
7. ELI Lilly and Company
8. Glaxosmithkline PLC
9. Merck & Co., Inc.
10. Abbvie Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
Request For Full Report- https://www.kennethresearch.com/sample-request-10008467
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Active Pharmaceutical Ingredients/APImarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
Name: Kenneth research
Phone: +1 313 462 0609